enVVeno Medical (NVNO) Non Operating Interest Expenses (2021)
enVVeno Medical (NVNO) posted Non Operating Interest Expenses of $867.0 for Q2 2021, down 97.32% on a QoQ basis from $32405.0 in Q1 2021.
Powered by 
Analysis
enVVeno Medical (NVNO) Non Operating Interest Expenses (2021) Analysis & Trends
enVVeno Medical has reported Non Operating Interest Expenses for 1 years, with the latest figure at $867.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 15.80 Mn |
| 10 | enVVeno Medical | 7.66 Mn | 7.66 Mn | - | - |